Dyspnea
304
30
35
175
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
21 trials with published results (7%)
Research Maturity
175 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.2%
22 terminated out of 304 trials
88.8%
+2.3% vs benchmark
6%
17 trials in Phase 3/4
12%
21 of 175 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 175 completed trials
Clinical Trials (304)
Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
Lung and Heart Function Across Decades of Life in Health
Dexamethasone in Controlling Dyspnea in Patients With Cancer
Evaluation of the Benefits of Hypnosis in Improving the Quality of Life of Patients With Chronic Obstructive Pulmonary Disease (COPD) Suffering From Persistent Dyspnea
Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
INSPIRatory Efforts Estimation Under High-flow Nasal Oxygen
Effect of Different Breathing Techniques on Dyspnea and Cardiopulmonary Parameters Among Patients After Open Heart Surgery
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
Improving Quality of Life and Daily Life Activities With Bioarginine in Patients With COPD
Effect of Non-invasive Magnetic Stimulation of the Brain on Breathlessness in Healthy Individuals.
Respiratory Physiotherapy and PMR After Cardiac Surgery
Arterial Stiffness for Improved Prediction of Coronary Artery Disease by Coronary CT Angiography
Asymmetric High-Flow Nasal Cannula During Pulmonary Rehabilitation in COPD
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Alleviating Dyspnea With Non-Invasive Neuromodulation